奥斯卡健康公司（Oscar Health，股票代码：OSCR）在夜盘交易中股价大涨5.05%，这一显著涨幅主要受到该公司发布的超预期季度财报推动。
根据最新公布的财务报告，截至2025年3月31日的季度中，奥斯卡健康公司实现调整后每股收益92美分，大幅超过分析师平均预期的79美分。公司营收同比增长42.2%，达到30.5亿美元，同样超过分析师预期的28.6亿美元。此外，公司报告的季度净收入高达2.7527亿美元，展现出强劲的盈利能力。这些数据均显著优于市场预期，凸显了公司的业务增长和运营效率。
值得注意的是，尽管过去三个月分析师的平均盈利预期下降了约2.6%，奥斯卡健康仍然交出了远超预期的成绩单。目前，华尔街分析师对该公司的12个月目标价中位数为16.00美元，多数分析师维持"持有"评级。这一亮眼的财务表现显著提升了投资者信心，可能进一步推动奥斯卡健康股价在未来一段时间内保持强劲势头。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.